In this feature, Lavin Vaswani of Quantcast takes a look at how AI can help brands master their targeting, and stretch limited budgets. Artificial Intelligence (AI) is one of 2024’s most talked about ...
AT03-65 is the first program utilizing AxcynDOT™, a proprietary payload with a differentiated mechanism of action, to enter clinical development SINGAPORE, Jan. 15, 2025 /PRNewswire/ -- Axcynsis ...
Internationally recognized radiopharmaceutical leader joins Actithera as the lead FAP-targeting asset advances to clinical development and the differentiated pipeline takes shape Brings over 15 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback